Curanex Pharmaceuticals Inc Stock Price

NasdaqCM:CURX Community·US$17.4m Market Cap

0 Narratives written by author
0 Comments on narratives written by author
0 Fair Values set on narratives written by author

Create a narrative

CURX Share Price Performance

US$0.62

-3.40 (-84.58%)

US$0.62

-3.40 (-84.58%)

US$0.62

Sat, 8 Nov 25

Share PriceUS$0.62

CURX Community Narratives

There are no narratives available yet.

Create a narrative

There are no community narratives available.

Snowflake Analysis

Slight risk with imperfect balance sheet.

4 Risks

0 Rewards

View Full Analysis

Curanex Pharmaceuticals Inc Key Details

Last Reported Earnings

Jun 30, 2025

Next Reporting Earnings

n/a

: -0.015
: 0%
: 0%
: 131.0%

View Full Analysis

About CURX

Founded: 1996
Employees: n/a
CEO: Jun Liu
WebsiteView website: www.curanexpharma.com

Curanex Pharmaceuticals Inc, a developmental stage pharmaceutical company, discovers, develops, and commercializes botanical drugs to treat patients suffering from inflammatory diseases. It develops Phyto-N for various therapeutic areas, including ulcerative colitis, atopic dermatitis, COVID-19, diabetes, nonalcoholic fatty liver disease, and gout. The company was formerly known as Fordman Pharma Inc. and changed its name to Curanex Pharmaceuticals Inc in November 2023. Curanex Pharmaceuticals Inc was founded in 1996 and is headquartered in Jericho, New York.